543
Views
5
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspring

Pages 442-448 | Received 12 Nov 2013, Accepted 28 Dec 2013, Published online: 21 Jan 2014

References

  • Mahadevan U, Kane S. American Gatroenterological Association Institute technical review on the use of gastrointestinal medication in pregnancy. Gastroenterology 2006;131:283–311.
  • Heetun Z, Brynes C, Neary P, O’Morain C. Review article: reproduction in the patient with inflammatory bowel disease. Aliment Phamacol Ther 2007;26:513–33.
  • Rahimi R, Nikfar S, Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs. A meta-analysis. Reprod Toxicol 2008;25:271–5.
  • Ban L, Tata LJ, Fiaschi L, Card T. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications. Gastroenterology 2013;146:76–84.
  • National Board of Health and Welfare. Centre for Epidemiology. The Swedish Medical Birth Register—a summary of content and quality. 2003. http://www.socialstyrelsen.se/Publikationer2003/2003–112–3.
  • National Board of Health and Welfare. Centre for Epidemiology. Registration of congenital malformations in Swedish health registers. 2004. http://www.socialstyrelsen.se/Publikationer2004/2004–112–1.
  • Källén B, Borg N, Reis M. The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) 2013;6:1221–86.
  • Källén B. Epidemiology of human congenital malformations. Cham, Heidelberg, New York, Dodrecht, London: Springer; 2014; Chapter 13.
  • Diav-Citrin O, Park YH, Veersuntharam G, Polachek H, Bologa M, Passtuszak A, et al. The safety of mesalazine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998;114:23–8.
  • Marteau P, Tennenbaum R, Elefant E, Lehmann M, Cosnes J. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine granules. Aliment Parmacol Ther 1998;12:1101–8.
  • Nørgård B, Fonager K, Pedersen K, Jacobsen BA, Sørensen HT. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003;52:243–7.
  • Nørgård B, Pedersen L, Christensen LA, Sørensen HT. Therapeutic drug use in women with Crohn´s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007;102:1406–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.